It is known that the Aβ peptide is present in peripheral blood, and recent results from Lam and colleagues, using genetically modified mice that produce human Aβ peptide in their livers, pointed to the fact that the peripheral metabolism of this peptide and APP might be related to AD risk [17]. Here, APP is linked to Alzheimer disease.